Clinical Trial Update: Side Effects of Bone Marrow Derived CD133 Transplantation in Cerebral Palsy [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update reporting safety and observed side effects of transplanting bone marrow-derived CD133+ cells in cerebral palsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Palsy

Drugs mentioned

• CD133+ bone marrow-derived cell therapy (CD133+ bone marrow-derived cells)

Snippet

Sponsor: Royan Institute | Conditions: Cerebral Palsy | Phase 1 | Status: COMPLETED